Implementing and evaluating virtual patient cases within a team‐based learning pedagogy in a therapeutics course sequence by Mohammad, Rima A. et al.
C L I N I C A L PHARMACY R E S E A R CH R E POR T
Implementing and evaluating virtual patient cases within a
team-based learning pedagogy in a therapeutics course
sequence
Rima A. Mohammad Pharm.D., FCCP1 | Vicki L. Ellingrod Pharm.D., FCCP1,2 |
Barry E. Bleske Pharm.D., FCCP3
1Department of Clinical Pharmacy, University
of Michigan College of Pharmacy, Ann Arbor,
Michigan
2School of Medicine, Department of
Psychiatry, University of Michigan, Ann Arbor,
Michigan
3College of Pharmacy, Department of
Pharmacy Practice and Administrative
Sciences, University of New Mexico,
Albuquerque, New Mexico
Correspondence
Rima A. Mohammad, University of Michigan,
College of Pharmacy, 428 Church Street, Ann
Arbor, MI 48109-1065.
Email: rimam@med.umich.edu
Introduction: Accreditation Council for Pharmacy Education (ACPE) requires that pharmacy cur-
riculum stresses active learning. This allows students to listen, read, write, discuss, and reflect
on their approach to course content through various methods. ACPE advocates use of innova-
tive, active learning teaching methods to develop necessary skills students need to problem-
solve, think critically, and effectively work as a team. We have successfully implemented team-
based learning (TBL) throughout therapeutics curriculum; however, there is still a critical need
for students to practice what they have learned through an interactive fashion. Use of virtual
patients has been previously evaluated in non-TBL courses and has resulted in improved stu-
dent learning. Thus, using virtual technology could bridge the gap between TBL and providing
“real-life” patient-centered care.
Objectives: To evaluate short-term learning outcomes and student perception of implementing
virtual simulation within a TBL therapeutics course series. We expect that virtual simulation will
add another unique action-based learning experience within TBL.
Methods: Faculty developed virtual patient cases using branched-outcome decision-making pro-
cesses and integrated them into six TBL sessions throughout the therapeutic courses in the sec-
ond (two sessions) and third years (four sessions) of pharmacy school. Students completed
virtual patient cases in groups and pre-simulation/post-simulation assessments were completed.
Assessments and activity evaluation were used to measure student learning and perceptions.
Pre-simulation/post-simulation assessments included 12 lower-level and 9 higher-level learning
questions.
Results: Use of virtual patient cases resulted in significantly higher post-simulation scores com-
pared with pre-simulation scores (P < 0.001). Increases in student's learning of lower- and
higher-level domains (P = 0.02 and P = 0.11, respectively) were observed. Seventy-four percent
of students agreed that virtual cases were effective in learning therapeutic clinical application,
and 80% believed these cases stimulated their critical thinking.
Conclusion: Integrating virtual patient cases into curriculum may enhance student's ability to
critically think and apply their knowledge to real health care world.
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1 | INTRODUCTION
The 2016 Accreditation Council for Pharmacy Education (ACPE) stan-
dards require that graduates from pharmacy schools have “knowledge,
skills, abilities, behaviors, and attitudes necessary to provide patient-
centered care.”1 Graduates are expected to provide this care as the
medication expert through effectively collecting and interpreting evi-
dence, formulating their assessments and recommendations,
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implementing those recommendations, monitoring patient's status,
and documenting activities appropriately. The Center for the
Advancement of Pharmacy Education (CAPE) 2013 educational out-
comes constructed domains to guide pharmacy schools in providing
graduates the knowledge and skills for patient-centered care, the abil-
ity to work with and educate other health care professionals, and the
problem-solving skills necessary to effectively care for patients.2
ACPE requires that pharmacy curriculum stresses an active learning
pedagogy, which actively engages learners during teaching. This
allows pharmacy students to listen, read, write, discuss, and reflect on
their approach to course content through various methods. ACPE
advocates the use of innovative, active learning teaching methods in
schools curricula to develop necessary skills students need to
problem-solve, think critically, and effectively work in an interprofes-
sional environment.1 Some of these teaching methods include patient
simulation utilizing educational technologies or actors, problem-based
learning (PBL), or team-based learning (TBL).
The University of Michigan College of Pharmacy has been a
leader in the TBL implementation, which is a teaching pedagogy that
“flips the classroom”.3–6 This active learning instruction was imple-
mented to improve long-term learning outcomes (eg, performance
during experiential rotations, clinical exams, and board exams) by uti-
lizing engaged, action-based learning experiences for students prior to
their advanced pharmacy practice experiences where they interact
with real-life patients. There have been several studies that support
using TBL in therapeutics. Students reported in a recent study that
TBL improves teamwork skills, learning both knowledge- and
application-based course content, and lifelong learning skills.4 Another
study randomized students to receive lecture- vs TBL activities
focused on six therapeutic topics.5 Results showed that there were
significantly higher exam scores and student survey scores focused on
critical thinking and therapeutic knowledge favoring TBL compared
with lecture format. While TBL implementation has been very suc-
cessful within our curriculum and has allowed us to measure some
outcomes (eg, knowledge scores, student confidence assessment, and
satisfaction survey of the activity), there is still a critical educational
need for our students to actually practice what they have learned
through TBL in an interactive fashion before directly working with real
patients within the health care system.4 Virtual patient technology
could be used to bridge the gap between TBL and providing “real-life”
patient-centered care as this technology simulates “real-life” clinical
scenarios for students to utilize their critical thinking skills. Virtual
patient simulation is defined by the American Association of Medical
Colleges (AAMC) as, “a specific type of computer-based program that
simulates real-life clinical scenarios; learners emulate the roles of
health care providers to obtain a history, conduct a physical exam, and
make diagnostic and therapeutic decisions”.7 Use of virtual
patients allows students to provide patient-centered care and to
take on the pharmacist role on a team by obtaining the necessary
patient information and making appropriate diagnosis and thera-
peutic recommendations.8
TBL provides an interactive approach for teaching curriculum and
material; however, we believe that virtual patient simulation imple-
mentation will add another significant and unique action-based learn-
ing experience in a TBL-based curriculum. The purpose of our study is
to evaluate short-term learning outcomes and student perception of
implementing virtual patient simulation activities within a TBL thera-
peutics curriculum.
2 | METHODS
2.1 | Description of the curricular activity
At University of Michigan College of Pharmacy, our therapeutics
course sequence began the second semester of first year of pharmacy
school (P1) and continued through the end of the third year of phar-
macy school (P3). Throughout the course sequence, TBL was the only
method used during the recitation sessions. As part of the TBL pro-
cess, students were required to complete prework (a guided self-study
or Microsoft PowerPoint recorded lectures) before class. During the
recitation class session, students conducted readiness assurance
assessments (individual and team-based readiness assessments) to
evaluate knowledge and basic application of prework material. After
the assessments were completed, students worked in teams to apply
knowledge obtained through prework on application-based activities
(eg, patient cases, role playing). In addition to recitations, laboratory
activities occurred throughout the semester once weekly. The labora-
tory sessions included application-based and clinical skills activities
and were focused on key curricular threads (eg, communication and
physical assessments) with current content taught during the recita-
tion session. Some of these laboratory activities included standardized
patient interactions, virtual patient simulation, skill assessments, and
case presentation. Virtual patient simulation was a method to provide
more real-life patient scenarios and critical-thinking based activities.
Virtual patient cases were integrated into six TBL sessions
throughout the therapeutic courses in the second (P2) and third years
(P3) of pharmacy school over four semesters. Two sessions were in
the P2 year and four sessions were in the P3 year. Implementation of
virtual simulation and activities were standardized regardless of topic
area or timing of session. Cases were not used to teach new material,
but to supplement and reinforce material presented in the prework
material and prior TBL sessions. DecisionSim technology (Chadds
Ford, Pennsylvania [www.kynectiv.com]) was used to introduce virtual
patient simulation to students during select sessions, which previously
had been discussed using paper-based cases. The sessions, which
replaced other teaching methods (eg, paper-based cases, role playing)
with virtual patient simulation, included pharmacokinetics, hepatology,
transplant, oncology, and two cardiology sessions. The virtual patient
case content were written by content experts and reviewed by virtual
simulation experts. The virtual patient cases were then reviewed and
tested by pharmacy students, faculty, or residents prior to the class
session. A consultant was available to answer any question regarding
the DecisionSim technology, as they had previous experience using
this program. Before faculty developed virtual simulation cases, all fac-
ulty involved received both group training provided by the Decision-
Sim trainer and one-on-one training by virtual simulation experts.
During the virtual patient simulation activity, students worked on
cases as a team of five or six students and they were given between
one and 2 hours to complete the cases. Immediately after students
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completed the virtual patient cases, the instructors discussed their
findings and key points in a large classroom setting and individual
assessments were completed. Following the activity, students had
open access to the virtual patient cases.
Virtual patient cases were developed using DecisionSim technol-
ogy, and several faculty members created and implemented the cases.
Faculty developed the virtual patient cases and used a branched-
outcome decision-making process, in which students were given
patient case scenarios and were to choose the best choice that could
lead them to the right or wrong path. Students received immediate
feedback of their choice and any consequences associated with those
choices. Immediate feedback was to mimic a situation in which a stu-
dent was making clinical recommendations to other health care pro-
fessionals for patient issues and for the student to see the clinical
outcome of that recommendation. An example of a virtual patient
case is presented in Figure 1. In addition, virtual patient cases were
developed from the learning objectives of the course section. Overall,
the purpose of using virtual patient cases was to provide a safe envi-
ronment for students to practice critical thinking skills, allow students
to apply the course content to these cases, provide instant feedback
to students as they progress through the cases, and provide a discus-
sion with the faculty after completion of the activity.
2.2 | Study design and assessments
This was a retrospective study to evaluate the impact of virtual simu-
lation cases on knowledge retention in a TBL therapeutics course
sequence. Knowledge retention was assessed by evaluating pre- and
post-simulation assessment scores of all pharmacy students included
in the study. This study included P2 and P3 students (from September
2015 to April 2016) who took part in the virtual simulation cases and
completed the pre- and post-assessments. The primary end point of
this study was change in pre- and post-assessment scores. A second-
ary end point included student satisfaction of the activity. The study
was approved as exempt status by the University of Michigan investi-
gational review board and student consent was not required to partic-
ipate in the simulation activity and study. We obtained funding
through the University of Michigan Third Century Initiative to support
our study. The funds allowed us to secure the virtual simulation soft-
ware program, DecisionSim.
This study utilized both quantitative and student evaluation data
to evaluate the effectiveness of a virtual simulation software program,
DecisionSim, on students. Pre- and post-simulation assessments (quiz-
zes) and an evaluation of the activity were used to assess student
learning and perceptions. The students were given a five or six
What are patient's PK  
parameters? 
Patient Admitted to hospital 
and patient information  
provided
Ask students to calculate
Clinical course: team wants 
to start vancomycin. Ask  
students for goal  
vancomycin levels
Levels come back. Ask  
students to calculate PK 
parameters and vancomycin 
maintenance dose
Students provide correct 
dose and feedback 
provided: team thanks 
student for dose
Ask students to recalculate 
CrCl
Students provide incorrect  
dose but could be using 
wrong CrCl. Patient clinical 
outcome is renal failure
Students provide incorrect  
dose but could be using 
incorrect weight. Patient 
clinical outcome is  
worsening infection
Ask students a question on 
appropriate weight to use in  
vancomycin dosing
FIGURE 1 Example of a virtual patient case. CrCL, creatinine clearance; PK, pharmacokinetics
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question (depending on the session) pre-simulation assessment prior
to the DecisionSim activity, followed by the same number of post-
simulation assessment questions and an evaluation survey after the
activity. All except one post-simulation assessment question were cre-
ated to be similar but not identical to the pre-simulation assessment
questions. The purpose of making the assessments different was to
prevent recall bias. Only five sessions (out of the six sessions) were
included in the data analysis of the pre- and post-simulation assess-
ment scores. Pre- and post-assessment scores of one of the sessions
were removed from the analysis due to the assessments being identi-
cal. Peer review of the assessment questions were conducted by the
course faculty members who were the content experts of the specific
virtual patient case activities. In addition, course teaching assistants
(eg, pharmacy residents) reviewed some of the questions to assess
appropriateness. All pre- and post-simulation assessments were devel-
oped from the learning objectives of the course section. The course
faculty based the level of difficulty of the questions based on the
Bloom's taxonomy of learning activity levels.9 We only included the
TBL sessions in the P3 year (four sessions) to evaluate lower-level (eg,
knowledge) and higher-level learning (eg, application). Out of all of the
questions included in the four sessions, a total of twelve lower-level
learning (pre- or post-assessment) and nine higher-level learning (pre-
or post-assessment) questions were evaluated. The evaluation survey
was developed by the study investigators and included
thirteen questions using a 5-point Likert scale and two questions
using free text responses. The survey was adapted from a survey used
in a previous study on virtual patients.10 Additional questions were
included in the survey to compare the use of traditional TBL activities
compared with virtual simulation cases. The evaluation survey was
administered to individual students after the activity to evaluate stu-
dent perceptions of, and satisfaction with, the teaching strategy. The
students were required to complete pre- and post-simulation assess-
ments and were strongly encouraged to complete the evaluation sur-
vey. Statistical analysis was conducted using IBM SPSS Software
(version 22). Pre- and post-simulation assessments were analyzed
using paired student's t tests. A p value of less than 0.05 indicates a
statistically significant difference. The results from the evaluation sur-
vey were presented as descriptive data.
3 | RESULTS
Overall, 156 students (n = 82 [P2], n = 74 [P3]) were participants in
the study. Table 1 summarizes the pre- and post-simulation assess-
ment results. Out of the 368 assessments (individual assessment of
student pre- and post-scores) from five of the sessions, virtual patient
simulation significantly increased the students' overall learning by
13.3% when comparing pre- and post-simulation assessment scores
(P < 0.001). A subgroup analysis was conducted to compare pre- and
post-simulation assessment scores between Fall (two sessions) and
Spring (three sessions) semesters. In the Fall semester, pre- and post-
simulation assessment scores were similar (72% vs 69.5%, respec-
tively; P = 0.17). However, in the Spring semester, post-simulation
assessment scores were significantly higher by 25% compared with
the pre-simulation assessment scores (P < 0.001). The virtual patient
simulation significantly increased the students' learning of lower-level
domains by 25.2% (P = 0.02). The difference in pre- and post-
simulation scores in learning of higher-level domains was 14.7%; how-
ever, it did not increase significantly (P = 0.11). Lower- and higher-
level domains were evaluated in the sessions in the Spring semester.
Virtual patient simulation significantly increased the students' learning
of lower-level domains by 18.1% when comparing pre- and post-
simulation scores (P = 0.019). The difference in pre- and post-
simulation scores in learning of higher-level domains was 15.7%; how-
ever, it did not increase (P = 0.26).
After the virtual patient simulation, students were provided a link
to complete an evaluation survey related to the virtual patient cases
as a teaching tool in the course. Two hundred and forty-eight surveys
were completed by the students (average response rate of 49.2% per
session). The students could have filled out a survey for each of the
sessions; therefore, there were more surveys completed compared
with the number of students that were involved in the activity.
Table 2 summarizes the student perceptions and results from the eval-
uation survey. Seventy-four percent of 248 students agreed or
strongly agreed that the virtual patient cases were an effective way to
learn clinical applications of therapeutics, 67% wanted more of these
cases incorporated into the therapeutic course sequence, 80%
believed that these cases stimulated their critical-thinking during the
recitation session, 72% agreed or strongly agreed that both TBL and
virtual patient cases should be utilized for therapeutic topics, and
60.5% enjoyed these cases. Additionally, 72% of students strongly dis-
agreed or disagreed that virtual patient cases should only be used for
recitation sessions; however, students were indifferent when asked if
TABLE 1 Results from the pre-simulation and post-simulation
quizzes (N = 368, individual assessment of student pre- and
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they prefer learning with the typical TBL recitation session instead of
learning with a virtual patient case (40% selected undecided).
4 | DISCUSSION
Incorporation of virtual patient simulation technology within an
embedded active learning pedagogy (TBL) in a core curricular class
sequence had a positive effect on learning outcomes on both student
learning and perceptions. There was significant improvement in over-
all post-simulation test scores with significantly higher scores
observed for knowledge-based questions. There were higher scores
seen for application-based questions; however, the difference was
not statistically significant. Additionally, the post-simulation test
scores were significantly higher in the Spring semester compared with
pre-simulation scores; however, there was no significant difference in
pre- and post-simulation test scores in the Fall semester. These results
could be due to students already having multiple exposures to the
virtual simulation technology prior to the Spring semester. Therefore,
these students would be expected to score better compared with the
Fall semester. In addition, approximately 80% of students agreed or
strongly agreed that critical thinking skills were stimulated using vir-
tual patient simulation technology. Overwhelmingly, the majority of
students (72%) also believed that both TBL and virtual patient tech-
nology should be used to teach therapeutic topics. Utilizing both vir-
tual patient simulation technology and TBL was well accepted by
students.
A novel aspect of this study is the evaluation of virtual patient
simulation technology embedded within an established active learning
pedagogy - TBL. Because TBL is the core pedagogy for our five
semester therapeutics sequence, our students are well versed in this
pedagogy which makes for an ideal setting to add a different active
learning strategy. Our findings suggest over 70% of students value
the use of virtual patient simulation technology in addition to TBL.
Importantly, the virtual patient simulation technology helped students
(approximately 71%) to understand the pre-work that is associated
TABLE 2 Results from the post-virtual patient case evaluation survey and student perceptions of the teaching tool
Student responses (N = 248; 6 TBL sessions)
Question Strongly agree n (%) Agree n (%) Undecided n (%) Disagree n (%) Strongly disagree n (%) N/A n (%)
The DecisionSim case was an
effective way to learn the clinical
application of therapeutics
34 (13.7) 149 (60.1) 36 (14.5) 18 (7.3) 11 (4.4) 0
More DecisionSim cases should be
incorporated into the
therapeutic course sequence
37 (14.9) 129 (52) 42 (16.9) 28 (11.3) 12 (4.8) 0
DecisionSim stimulated my critical
thinking during the recitation
session
50 (20.2) 149 (60.1) 28 (11.3) 11 (4.4) 10 (4) 0
I enjoyed using DecisionSim for the
recitation session
36 (14.5) 114 (46) 50 (20.2) 31 (12.5) 17 (6.9) 0
I learned more using the
DecisionSim case as compared
with a typical TBL recitation
period
17 (6.9) 52 (21) 90 (36.3) 63 (25.4) 25 (10.1) 1 (0.4)
Only DecisionSim cases should be
used for recitation sessions
5 (2) 22 (8.9) 43 (17.3) 96 (38.7) 82 (33.1) 0
I accessed the DecisionSim case
after the recitation session to
help study for the exam
27 (10.9) 61 (24.6) 21 (8.5) 82 (33.1) 52 (21) 5 (2)
The degree of difficulty in the
DecisionSim case helped me to
prepare for the exam questions
16 (6.5) 115 (46.4) 80 (32.3) 25 (10.1) 11 (4.4) 1 (0.4)
The content on the DecisionSim
case was appropriate for the
therapeutic area
42 (16.9) 165 (66.5) 27 (10.9) 10 (4) 4 (1.6) 0
The learning objectives for the
recitation period were met
during the DecisionSim case
20 (8.1) 150 (60.5) 39 (15.7) 28 (11.3) 10 (4) 1 (0.4)
The DecisionSim case contributed
to my understanding of the
material from the prework
33 (13.3) 144 (58.1) 38 (15.4) 16 (6.4) 16 (6.4) 1 (0.4)
I prefer learning with the TBL
recitation session instead of
learning with a DecisionSim case
41 (16.5) 55 (22.2) 99 (39.9) 46 (18.6) 5 (2) 2 (0.8)
For a therapeutic topic (eg, solid
organ transplant) both a typical
TBL recitation session and a
DecisionSim case should be
utilized
74 (29.9) 105 (42.3) 47 (19) 12 (4.8) 10 (4) 0
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with TBL. However, the data suggests that students do not believe
that virtual patient simulation technology should replace TBL. Specifi-
cally, only 20% of students disagreed with the statement “I prefer
learning with the TBL recitation session instead of learning with a
DecisionSim™ case”. Further, only 10% of students agreed that “Only
DecisionSim™ cases should be used for recitation sessions”.
Overall, our study results, especially pre- and post-simulation test
scores and student survey results, were consistent with a prior study
that evaluated the use of DecisionSim™ to develop and implement a
patient case activity.10 A few schools implemented and evaluated the
effectiveness and student satisfaction in utilizing virtual patient simu-
lation technology in the pharmacy curriculum. One study evaluated
the use of a virtual patient system to create real clinical cases to teach
pharmaceutical care and communication skills to pharmacy students.11
The results demonstrated that students strongly agreed that they
found the cases realistic and that they learned from using the system.
Another study evaluated the use of virtual patient cases in an
advanced therapeutics pharmacy course to promote active, patient-
centered learning.10 Cases were developed that incorporated a
branched-narrative, decision-making teaching model and pre-simula-
tion/post-simulation tests were used to assess student learning. The
use of virtual patient cases resulted in significant improvement in stu-
dent learning for both high-level and low-level test questions. Addi-
tionally, students were satisfied with using virtual patient simulation
and agreed/strongly agreed that the cases were enjoyable (69%), con-
tent was appropriate (80%), and cases were an effective way to learn
(72%). Fifty-nine percent of students also wanted to see more cases
incorporated throughout the course. A recent study evaluated the use
of one virtual patient case in one required therapeutics course using a
flipped-classroom teaching format.12 Similar to the previous study,10
the case incorporated a branched-narrative, decision-making teaching
model and pre-simulation/post-simulation tests were used. The
results showed that median post-simulation test scores were 17%
higher than pre-simulation test scores (50% vs 33%, P = 0.01; respec-
tively). Students scored significantly higher on the post-simulation test
questions compared with pre-simulation test questions assessing
high-level learning (83% vs 67%, P = 0.003; respectively). Median
exam scores were also evaluated and were higher compared with his-
torical control scores (80% vs 70%, P = 0.025; respectively). Addition-
ally, 67.6% of students agreed or strongly agreed that the virtual
patient case helped them apply knowledge gained in video pre-
work.12 More recently, a study compared the use of a virtual simu-
lated patient case vs a paper-based case on a subjective objective
assessment plan (SOAP) and 13 student-perceived confidence items
in medication management.13 Results showed that there was a signifi-
cant increase in all confidence items; however, there was no differ-
ence in total SOAP note scores between groups. Overall, the studies
showed that virtual patient simulation is a useful teaching tool. How-
ever, key strengths of our study were that this study included more
virtual patient cases throughout a therapeutics course sequence,
including content in P2 and P3 years, and the activities were incorpo-
rated into a curriculum with TBL.
Limitations of our study included that administration of the sur-
vey immediately after the activity may not capture students' feed-
back on exam preparation, and a lack of a comparative group that
included a pre-implementation group with a similar activity without
the use of virtual patient simulation. Other limitations we have
learned from this study included the use of nonvalidated assess-
ments, and obstacles to consider when using a virtual simulation
platform and when developing virtual patient cases. In regards to
using nonvalidated assessments, we conducted a review of the
assessments to ensure assessments were linked to learning objec-
tives of the course section and that the level of difficulty was appro-
priate for students. However, it was difficult for us to validate the
assessment due to the variation of topics covered in the six sessions.
A second limitation to consider before implementation of virtual
simulation was the costs associated with using a virtual simulation
platform. Additionally, there are significant resources, specifically
faculty time that is required to develop these virtual patient cases.
One study reported that approximately 50 hours was dedicated to
developing and implementing virtual patient cases.10 However, with
future use of these cases, it is expected that there would be minimal
time needed to update and implement these cases. Additionally, vir-
tual patient case sharing across schools may allow universities to
overcome barriers, such as faculty time and resources, which may
prevent implementation of virtual patient simulation activities in the
classroom.14 Schools may not have the resources to utilize a virtual
simulation program; however, simulation could be done using other
techniques but must maintain key elements of a virtual simulation
approach: 1. Cases must use a branched-outcome decision making
process, in which the students are given patient case scenarios and
are to choose the best choice that could lead them to the wrong or
right path, and 2. Students receive immediate feedback of their
choice and any consequences associated with those choices.
5 | CONCLUSION
Overall, incorporating virtual patient simulation within TBL had a
positive effect on learning outcomes for both student learning and
perceptions. We believe that this type of simulation program is opti-
mal for student learning, especially in P2 and P3 students, because
as already stated, they will be able to immediately see the impact of
their decisions related to medication therapy and how patient out-
comes are directly related to these recommendations. Implementa-
tion of virtual patient simulations may have significant potential to
create sustainable change in how our students are educated, as fac-
ulty can easily adapt and create new cases as new medications
become available or as treatment guidelines change. Virtual simula-
tion allows for critical reinforcement of the application principals
taught within our TBL pedagogy and creates a necessary intermedi-
ate step between classroom and clinic that our curriculum is cur-
rently lacking. We feel that this one relatively simple change in how
we teach our students will greatly enhance their ability to critically
think and apply their knowledge to the real health care world. Future
studies are needed to compare the effectiveness of virtual simula-
tion and traditional teaching (eg, lecture) in student learning in the
TBL setting.
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